|
US2020003795A1
|
|
Determination of analytes in liquid samples by mass spectrometry
|
|
US2019170774A1
|
|
Detection of vitamins A and E by tandem mass spectrometry
|
|
WO2019023593A1
|
|
Container for a specimen and method of using same
|
|
US10708345B1
|
|
Automated delivery of alerts with confirmation of receipt
|
|
US2017316149A1
|
|
Classification of genetic variants
|
|
US2017343568A1
|
|
Prognostic assays for maintenance hemodialysis patients
|
|
EP3368667A1
|
|
Methods for cell-free dna extraction for non-invasive prenatal screening
|
|
US2016245820A1
|
|
Detection apparatus for differential-charged particle mobility analyzer
|
|
US2016312303A1
|
|
Methods and compositions for the detection of CALR mutations in myeloproliferative diseases
|
|
US2018291426A1
|
|
MLH1 methylation assay
|
|
US2017073669A1
|
|
RNA isolation from soluble urine fractions
|
|
CN107849564A
|
|
For detecting the measure of pathogenic leptospire bacterial strain
|
|
CA2980327A1
|
|
Alignment and variant sequencing analysis pipeline
|
|
US2016176920A1
|
|
Magnetic separation of lipoproteins using dextran sulfate
|
|
CN107250377A
|
|
The amplification and detection of nucleic acid in biological sample
|
|
US2016061850A1
|
|
Mass spectrometric quantitation for metabolites of leflunomide
|
|
WO2016190897A1
|
|
Compositions and methods for screening solid tumors
|
|
US10679294B1
|
|
Methods for estimating mortality risk of an individual among a peer group
|
|
US10030276B1
|
|
Detection of Mycobacterium tuberculosis complex nucleic acids
|
|
US2017292868A1
|
|
Device and method for evaluating amount of biological sample in a specimen container
|
